Agreements reached under this partnership
Joint venture- 1
Exclusive commercialization, distribution and support services for CC products in the Japanese market
- 2
Strategic provision and joint development in Japan of the Genie AI Engine series
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The parties aim to acquire new customers and expand revenue. Specific targets and the timing for their achievement are not disclosed.
This indicates whether the companies will do more than work together, such as holding each other’s shares or seconding personnel (capital and business alliance).
The impact on the Company's results for the fiscal year ending December 2026 is currently under review. The Company will promptly disclose any matters requiring disclosure that arise in the future. The joint venture is expected to be included in the Company's scope of consolidation from May 2026.
| Item | Details |
|---|---|
| Name of alliance partner | CustIntCo Pte Ltd. |
| Alliance partner's business activities | IT integration and cloud solution services |
| Alliance partner's location | Singapore |
| Alliance partner's capital | Not disclosed at the request of the other party. |
| Type of alliance | Joint venture |
| Details of the alliance | Exclusive commercialization, distribution and support services for CC products in the Japanese market, Strategic provision and joint development in Japan of the Genie AI Engine series |
| Shareholding ratio | 100% held by the Company (upon establishment) → Our company 51%; CC 49% |
| Overview of the joint venture | Name: CustIntCo Japan Co., Ltd.; location: 3-28-5 Kanda Ogawamachi, Chiyoda-ku, Tokyo (予定); business: exclusive commercialization, distribution and support services for CC products in the Japanese market; capital contribution: ¥10 million; ownership: 51% for the Company and 49% for CC (予定) |
| Ownership ratio | 51% for the Company and 49% for CC (the joint venture is expected to be established initially with the Company holding 100%) |
| Dispatch of directors and officers | Representative Director: Tanaka Yusei (田中優成). The acceptance and dispatch of directors and corporate auditors are not disclosed. |
| Numerical targets under the alliance | The parties aim to acquire new customers and expand revenue. Specific targets and the timing for their achievement are not disclosed. |
| Date of board resolution | 8 April 2026 |
| Contract Date | 8 April 2026 (joint venture agreement executed) |
| Alliance start date | Mid-May 2026 (予定) |
| Share Acquisition Date and Payment Date | CC is expected to subscribe to a capital increase after approval of the prior examination under the Foreign Exchange and Foreign Trade Act. The specific date is not disclosed. |
| Impact on Business Performance | The impact on the Company's results for the fiscal year ending December 2026 is currently under review. The Company will promptly disclose any matters requiring disclosure that arise in the future. The joint venture is expected to be included in the Company's scope of consolidation from May 2026. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The parties will jointly develop high-value-added solutions that address corporate mental health and healthcare challenges by leveraging CC's AI technology. The Company aims to shift from agency sales to developing a solutions business, thereby acquiring new customers and expanding revenue.